Table 3.
(A) Rates of volumetric reduction success (endpoint: ≥ 50%) at 1-, 3- and 6-month follow-ups, expressed as numbers and rates; (B) rates of volumetric reduction success (endpoint: ≥ 7 mL) at 1-, 3- and 6-month follow-ups, expressed as numbers and rates.
ATN (n = 18) | FTN (n = 18) | p value | |
---|---|---|---|
A | Success rate (endpoint: ≥ 50%) | ||
1 month | 6/18 (33.3%) | 3/18 (16.7%) | 0.44 |
3 months | 10/18 (55.6%) | 12/18 (66.7%) | 0.73 |
6 months | 11/18 (61.1%) | 16/18 (88.9%) | 0.12 |
B | Success rate (endpoint: ≥ 7 mL) | ||
1 month | 6/18 (33.3%) | 7/18 (38.9%) | 0.72 |
3 months | 13/18 (72.2%) | 14/18 (77.8%) | 0.70 |
6 months | 13/18 (72.2%) | 15/18 (83.3%) | 0.42 |
p values were derived from Fisher’s exact test
ATN adjustable-tip needle, FTN fixed-tip needle